Second pregnancy-associated Wilms tumor 16 years after the first one
Corresponding Author
Tung Wynn MD
Section of Hematology/Oncology, Columbus Children's Hospital, Ohio
Tung Wynn is a Fellow in Pediatric Hematology/Oncology.
Columbus Children's Hospital, 700 Children's Dr., Columbus, OH 45205.Search for more papers by this authorFrederick B. Ruymann MD
Section of Hematology/Oncology, Columbus Children's Hospital, Ohio
Frederick B. Ruymann is Director of the Section of Hematology/Oncology.
Search for more papers by this authorDenis R. King MD
Section of Pediatric Surgery, Columbus Children's Hospital, Ohio
Search for more papers by this authorMark Luquette MD
Department of Pathology, Columbus Children's Hospital, Ohio
Mark Luquette is Staff Pathologist in the Department of Pathology.
Search for more papers by this authorCorresponding Author
Tung Wynn MD
Section of Hematology/Oncology, Columbus Children's Hospital, Ohio
Tung Wynn is a Fellow in Pediatric Hematology/Oncology.
Columbus Children's Hospital, 700 Children's Dr., Columbus, OH 45205.Search for more papers by this authorFrederick B. Ruymann MD
Section of Hematology/Oncology, Columbus Children's Hospital, Ohio
Frederick B. Ruymann is Director of the Section of Hematology/Oncology.
Search for more papers by this authorDenis R. King MD
Section of Pediatric Surgery, Columbus Children's Hospital, Ohio
Search for more papers by this authorMark Luquette MD
Department of Pathology, Columbus Children's Hospital, Ohio
Mark Luquette is Staff Pathologist in the Department of Pathology.
Search for more papers by this author
REFERENCES
- 1 Bozeman G, Bissada NK, Abboud MR, et al. Adult Wilms tumor: prognostic and management considerations. Urology 1995; 45: 1055–1058.
- 2 Davis LW. Wilms tumor complicating pregnancy: a report of a case. J Am Osteopath Assoc 1987; 4: 306–309.
- 3 Green DM, Breslow NE, Beckwith JB, et al. Comparasion between single-dose and divided-dose administration of dactinomycin and doxorubicin for patients with Wilms tumor: a report from the National Wilms Tumor Study Group. J Clin Oncol 1998; 16: 237–245.
- 4
Arrigo S,
Beckwith JB,
Sharples K, et al.
Better survival after combined modality care for adults with Wilms tumor.
Cancer
1990;
66:
827–830.
10.1002/1097-0142(19900901)66:5<827::AID-CNCR2820660502>3.0.CO;2-0 CAS PubMed Web of Science® Google Scholar
- 5 Kilton L, Matthews MJ, Cohen MH. Adult Wilms tumor: a report of prolonged survival and review of the literature. J Urol 1986; 124: 1–5.
- 6 Foot NC, Humphreys GA, Whitmore WF. Renal tumors: pathology and prognosis in 295 cases. J Urol 1951; 66: 190–197.
- 7 Singh NP, Anuradha S, Choudhry D, et al. An unusual tumour in a post-partum woman. Postgrad Med J 1999; 75: 61–63.
- 8
Rosen G,
Caparros B,
Huvos AG.
Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based upon the response of the primary tumor to preoperative chemotherapy.
Cancer
1982;
49:
1221–1230.
10.1002/1097-0142(19820315)49:6<1221::AID-CNCR2820490625>3.0.CO;2-E CAS PubMed Web of Science® Google Scholar
- 9
Zuppan CW,
Beckwith JB,
Weeks DA, et al.
The effect of preoperative therapy on the histologic features of Wilms' tumor: an analysis of cases from the third National Wilms' Tumor Study.
Cancer
1991;
68:
385–394.
10.1002/1097-0142(19910715)68:2<385::AID-CNCR2820680229>3.0.CO;2-T CAS PubMed Web of Science® Google Scholar
- 10 Brosman RF, Williams DI. Bilateral nephroblastoma. J Urol 1973; 110: 119–124.
- 11 Gottesman JE, Pellettiere EV, Kilmer W. Recurrence of Wilms tumor—twenty-three years later. Urology 1981; 17: 268–269.
